None listed
Conditions
Brief summary
This randomised controlled trial will determine whether a 12 week, outpatient, supervised exercise training program, followed by a home-based maintenance exercise program, is safe and improves exercise capacity and quality of life (QoL) in patients with PAH.
Interventions
Sponsors
Study design
Eligibility
Inclusion criteria
Idiopathic or familial PAH WHO functional class II and III Medically stable On PAH-specific medication for at least 3 months prior to enrolment Able/willing to attend an exercise class and continue with a home exercise program
Exclusion criteria
PAH associated with connective tissue diseases Require oxygen therapy Significant musculoskeletal, neurological or cognitive impairments that limit the ability to perform in a class environment Involvement in a supervised exercise program within the last 12 months